1. Home
  2. CNTA vs CXW Comparison

CNTA vs CXW Comparison

Compare CNTA & CXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • CXW
  • Stock Information
  • Founded
  • CNTA 2020
  • CXW 1983
  • Country
  • CNTA United Kingdom
  • CXW United States
  • Employees
  • CNTA N/A
  • CXW N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • CXW Real Estate Investment Trusts
  • Sector
  • CNTA Health Care
  • CXW Real Estate
  • Exchange
  • CNTA Nasdaq
  • CXW Nasdaq
  • Market Cap
  • CNTA 2.3B
  • CXW 2.4B
  • IPO Year
  • CNTA 2021
  • CXW 1997
  • Fundamental
  • Price
  • CNTA $16.46
  • CXW $22.94
  • Analyst Decision
  • CNTA Strong Buy
  • CXW Buy
  • Analyst Count
  • CNTA 8
  • CXW 3
  • Target Price
  • CNTA $23.71
  • CXW $24.67
  • AVG Volume (30 Days)
  • CNTA 470.8K
  • CXW 1.0M
  • Earning Date
  • CNTA 11-12-2024
  • CXW 02-10-2025
  • Dividend Yield
  • CNTA N/A
  • CXW N/A
  • EPS Growth
  • CNTA N/A
  • CXW 17.92
  • EPS
  • CNTA N/A
  • CXW 0.67
  • Revenue
  • CNTA $6,853,000.00
  • CXW $1,973,599,000.00
  • Revenue This Year
  • CNTA N/A
  • CXW $3.71
  • Revenue Next Year
  • CNTA N/A
  • CXW $3.15
  • P/E Ratio
  • CNTA N/A
  • CXW $34.16
  • Revenue Growth
  • CNTA N/A
  • CXW 5.16
  • 52 Week Low
  • CNTA $7.38
  • CXW $10.74
  • 52 Week High
  • CNTA $18.97
  • CXW $24.99
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 50.86
  • CXW 61.38
  • Support Level
  • CNTA $14.61
  • CXW $21.30
  • Resistance Level
  • CNTA $17.65
  • CXW $23.45
  • Average True Range (ATR)
  • CNTA 1.08
  • CXW 0.93
  • MACD
  • CNTA -0.10
  • CXW 0.04
  • Stochastic Oscillator
  • CNTA 56.74
  • CXW 69.40

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

About CXW CoreCivic Inc.

CoreCivic Inc is an owner and operator of private prisons and detention centers in the United States. It operates in three segments: Safety, Community, and Properties. The Community segment owns and operates residential reentry centers. The Properties segment owns properties for lease to third parties and government agencies. The vast majority of the company's revenue comes from the CoreCivic Safety segment which consists of correctional and detention facilities that are owned, or controlled via a long-term lease, and managed by the company, as well as those correctional and detention facilities owned by third parties but managed by CoreCivic.

Share on Social Networks: